Skip to main content
. 2012 May 15;185(10):1073–1080. doi: 10.1164/rccm.201111-2075OC

TABLE 2.

MULTIRESPONSE PERMUTATION PROCEDURE ANALYSIS OF TRFLP PRODUCTS

T Value A Value P Value
Smoker control vs. cystic fibrosis −7.92 0.24 1.26 × 10−5
Smoker control vs. COPD (GOLD 4) −7.80 0.35 0.0001
Smoker control vs. nonsmoker control 1.04 −0.03 0.86
Cystic fibrosis vs. COPD (GOLD 4) −5.68 0.19 0.0002
Cystic fibrosis vs. nonsmoker control −7.37 0.21 8.86 × 10−6
COPD (GOLD 4) vs. nonsmoker control −7.80 0.34 0.0001

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative for COPD; TRFLP = terminal restriction fragment length polymorphism.